Home › Mga Autoimmune na Sakit
Pag-aaral pangklinika para sa Mga Autoimmune na Sakit na nagre-recruit sa U.S.
76 pag-aaral para sa Mga Autoimmune na Sakit ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX21 pag-aaral
- Washington, DC19 pag-aaral
- New York City, NY19 pag-aaral
- Philadelphia, PA16 pag-aaral
- Durham, NC15 pag-aaral
- Boston, MA13 pag-aaral
- Los Angeles, CA12 pag-aaral
- Chicago, IL12 pag-aaral
- Dallas, TX9 pag-aaral
- Atlanta, GA8 pag-aaral
- Portland, OR8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Cleveland, OH8 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Seattle, WA7 pag-aaral
- Orange, CA7 pag-aaral
- San Francisco, CA7 pag-aaral
- Louisville, KY6 pag-aaral
- The Bronx, NY6 pag-aaral
- Mountain View, CA6 pag-aaral
- Jacksonville, FL6 pag-aaral
- Kansas City, KS6 pag-aaral
- Salt Lake City, UT6 pag-aaral
- Baltimore, MD6 pag-aaral
- Rochester, MN6 pag-aaral
- Ann Arbor, MI6 pag-aaral
- Miami, FL6 pag-aaral
- Memphis, TN6 pag-aaral
- San Diego, CA5 pag-aaral
- Aurora, CO5 pag-aaral
- Sacramento, CA5 pag-aaral
- New Haven, CT5 pag-aaral
- Nashville, TN5 pag-aaral
- Greenville, NC4 pag-aaral
- Indianapolis, IN4 pag-aaral
- Kansas City, MO4 pag-aaral
- Charleston, SC4 pag-aaral
- Phoenix, AZ4 pag-aaral
- Worcester, MA4 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona6 pag-aaral
- Arkansas3 pag-aaral
- California27 pag-aaral
- Colorado8 pag-aaral
- Connecticut5 pag-aaral
- District of Columbia6 pag-aaral
- Florida20 pag-aaral
- Georgia10 pag-aaral
- Illinois14 pag-aaral
- Indiana4 pag-aaral
- Iowa7 pag-aaral
- Kansas7 pag-aaral
- Kentucky8 pag-aaral
- Maryland21 pag-aaral
- Massachusetts16 pag-aaral
- Michigan9 pag-aaral
- Minnesota9 pag-aaral
- Missouri7 pag-aaral
- Nebraska3 pag-aaral
- New Jersey5 pag-aaral
- New York24 pag-aaral
- North Carolina18 pag-aaral
- Ohio13 pag-aaral
- Oklahoma4 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania21 pag-aaral
- South Carolina4 pag-aaral
- Tennessee10 pag-aaral
- Texas22 pag-aaral
- Utah7 pag-aaral
- Virginia6 pag-aaral
- Washington8 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Environmental Risk Factors for the Anti-synthetase Syndrome
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02579967Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07621809Natural History of Bronchiectasis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00943514NIAID Centralized Sequencing Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 100 Years · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03206099Secukinumab Open Label Roll-over Extension Protocol
Nagre-recruitPhase 4
Edad 6 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04638647Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04097561Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Nagre-recruitPhase 2
Edad 4 hanggang 69 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04339777A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07541287Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Nagre-recruitObservasyonal na pag-aaral
1 Month – 100 Years · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00246857Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 99 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00001350Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT00977977Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07513181A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06154252A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Nagre-recruitPhase 2
Edad 16 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07328581Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05671757METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Nagre-recruitPhase 2
Edad 18 hanggang 69 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07699380A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07059000A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318PS-002 for the Treatment of IgA Nephropathy in Adults
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07182227A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.